AtonRa Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$272K Sell
4,193
-384
-8% -$23.1K 0.54% 80
2023
Q3
$299K Sell
4,577
-110
-2% -$6.92K 0.63% 78
2023
Q2
$273K Sell
4,687
-1,070
-19% -$67.5K 0.42% 105
2023
Q1
$355K Sell
5,757
-809
-12% -$48.5K 0.52% 92
2022
Q4
$417K Buy
+6,566
New +$476K 0.53% 82

Other funds holding NARI

AtonRa Partners's NARI Position: Q4 2023 in Review

AtonRa Partners reduced its Inari Medical, Inc. Common Stock (NARI) stake by 8.4% in Q4 2023, selling an estimated $23.1K and leaving 4,193 shares worth $272K. The position accounts for 0.54% of the portfolio, ranked #80.

AtonRa Partners first reported a position in NARI in Q4 2022 and has held it in 5 quarters since. The position peaked at $417K in Q4 2022. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

  • AtonRa Partners held 4,193 shares of Inari Medical, Inc. Common Stock worth $272K as of Q4 2023.
  • AtonRa Partners sold 384 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $23.1K.
  • Inari Medical, Inc. Common Stock made up 0.54% of AtonRa Partners's portfolio in Q4 2023, its #80 holding.
  • AtonRa Partners first reported a position in Inari Medical, Inc. Common Stock in Q4 2022 and has held it in 5 quarters since.
  • AtonRa Partners's Inari Medical, Inc. Common Stock position peaked at $417K in Q4 2022.
  • 252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.